Impact focus GHIC is an impact investment firm with a mission to improve global health and now global health security and pandemic preparedness, suggesting opportunities to position products and services that measurably enhance health outcomes and resilience.

Strategic partnerships History of public-private collaboration with BARDA and other investors indicates receptiveness to joint ventures, co-development, and government-aligned funding programs that could be leveraged for scale and regulatory navigation.

Portfolio scale Recent multi-million dollar investments in Centivax, Antheia, and Aerska imply GHIC seeks cutting-edge biotech and delivery technologies; target opportunities in RNA therapeutics, brain delivery, and biomanufacturing efficiency.

Global reach With a global health focus that has funded products impacting over 100 million lives and a diversified tech stack, GHIC presents opportunities for scalable solutions, cloud-based platforms, and secure compliance tools across regions.

Security readiness GHIC expanded into global health security and pandemic preparedness, creating a market for risk assessment, surveillance, rapid diagnostics, and supply chain resilience solutions aligned with public health priorities.